AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 175 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,155,000 | -90.4% | 100,000 | -83.3% | 0.21% | -88.6% |
| Q1 2018 | $12,066,000 | +33.2% | 598,800 | +99.6% | 1.88% | +237.5% |
| Q4 2015 | $9,057,000 | -81.5% | 300,000 | -73.8% | 0.56% | -73.8% |
| Q4 2014 | $48,888,000 | +1.4% | 1,147,060 | -24.1% | 2.12% | -58.0% |
| Q3 2014 | $48,209,000 | -40.7% | 1,510,775 | -61.5% | 5.05% | +26.4% |
| Q2 2014 | $81,254,000 | +384.3% | 3,921,550 | +352.3% | 4.00% | +146.0% |
| Q1 2014 | $16,779,000 | – | 867,117 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |